Pembrolizumab is effective after several courses of treatment

The effectiveness of pembrolizumab varies between individuals and the type of cancer. In general, pembrolizumab is usually administered continuously, with doses given every two to three weeks. The effects of medications take time to develop, so significant therapeutic effects are often not immediately visible within the first few courses of treatment.

In some studies, the therapeutic effects of pembrolizumab usually began to appear after 2 to 3 cycles of treatment. However, specific efficacy and response time will still vary based on individual differences and different cancer types. Some patients may see the effects of treatment in a shorter period of time, while others may take longer to see significant improvement. Doctors will evaluate efficacy based on each patient's specific circumstances, disease characteristics, and treatment response, and make adjustments if necessary. Therefore, it is very important for patients to work closely with their doctors, follow their doctor's orders, and promptly report any symptoms or changes to their doctors.

PembrolizumabThe original drug is already on the market in China. SpecificationsThe price per box of 100mg/4ml may be around RMB 15,000. This drug is a strictly controlled drug and has not yet been included in medical insurance. Pembrolizumab The price of the European version of the original drug 100mg/4ml per box may be around RMB 25,000, and the price of the Turkish version of 100mg/4ml per box may be around 10,000 RMB (the price may fluctuate due to the exchange rate). The ingredients of the original drugs at home and abroad are basically the same, and they are expensive. There are currently no generic versions of Pembrolizumab available overseas.